TWO SIGMA INVESTMENTS, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1179392 NEW YORK, NY

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$51,695,043

+$49,813,548 QoQ

Shares Held

409,174

+2930.9% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#206

of 2,266 holders

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Mar 31, 2026

CallValue

$529,606

CallShares

3,800

PutValue

$836,220

PutShares

6,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. GILD ranks #5 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	10,085,383	$581,119,768
2	AMGN	Amgen Inc	1,128,681	$408,717,963
3	LLY	ELI LILLY & Co	81,240	$97,441,701
4	AZN	Astrazeneca PLC	329,087	$62,401,476
5	GILD	Gilead Sciences, Inc. This page	409,174	$51,695,043
6	ABBV	AbbVie Inc.	198,249	$49,887,378
7	JNJ	Johnson & Johnson	34,909	$8,865,838
8	PFE	Pfizer Inc	330,300	$7,953,624

All Filings in GILD

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$51,695,043	409,174	+2930.9%	Shares	Sole	2026-08-14
2026-03-31	$529,606	3,800	-25.5%	Call	Sole	2026-05-15
2026-03-31	$1,881,495	13,500	-68.9%	Shares	Sole	2026-05-15
2026-03-31	$836,220	6,000	0.0%	Put	Sole	2026-05-15
2025-12-31	$736,440	6,000	-96.7%	Put	Sole	2026-02-17
2025-12-31	$625,974	5,100	-94.3%	Call	Sole	2026-02-17
2025-03-31	$4,862,970	43,400	-81.9%	Shares	Sole	2025-05-15
2024-12-31	$22,165,289	239,962	-65.7%	Shares	Sole	2025-02-14
2024-09-30	$58,576,828	698,674	-79.0%	Shares	Sole	2024-11-14
2024-06-30	$228,718,776	3,333,607	+4.3%	Shares	Sole	2024-08-14
2024-03-31	$234,156,297	3,196,673	+16724.6%	Shares	Sole	2024-05-15
2023-12-31	$1,539,190	19,000	-99.2%	Shares	Sole	2024-02-14
2023-09-30	$184,176,740	2,457,656	+187.3%	Shares	Sole	2023-11-14
2023-06-30	$65,923,597	855,373	-63.9%	Shares	Sole	2023-08-14
2023-03-31	$196,558,087	2,369,026	-19.9%	Shares	Sole	2023-05-15
2022-12-31	$253,754,743	2,955,792	-17.0%	Shares	Sole	2023-02-14
2022-09-30	$219,674,326	3,560,939	+11.1%	Shares	Sole	2022-11-14
2022-06-30	$198,156,369	3,205,895	+26.2%	Shares	Sole	2022-08-15
2022-03-31	$151,070,178	2,541,130	+74.5%	Shares	Sole	2022-05-16
2021-12-31	$13,244,064	182,400	-2.7%	Put	Sole	2022-02-14
2021-12-31	$6,462,290	89,000	-46.8%	Call	Sole	2022-02-14
2021-12-31	$105,725,315	1,456,071	-53.4%	Shares	Sole	2022-02-14
2021-09-30	$13,096,875	187,500	-23.9%	Put	Sole	2021-11-15
2021-09-30	$218,349,004	3,125,970	+326.1%	Shares	Sole	2021-11-15
2021-09-30	$11,678,920	167,200	-6.2%	Call	Sole	2021-11-15
2021-06-30	$50,515,489	733,597	+370.6%	Shares	Sole	2021-08-16
2021-06-30	$16,967,104	246,400	-54.9%	Put	Sole	2021-08-16
2021-06-30	$12,270,852	178,200	-61.2%	Call	Sole	2021-08-16
2021-03-31	$29,678,096	459,200	+401.3%	Call	Sole	2021-05-17
2021-03-31	$35,275,054	545,800	+104.6%	Put	Sole	2021-05-17
2020-12-31	$5,336,616	91,600	-70.9%	Call	Sole	2021-02-16
2020-12-31	$9,081,452	155,878	+335.7%	Shares	Sole	2021-02-16
2020-12-31	$15,543,768	266,800	-9.7%	Put	Sole	2021-02-16
2020-09-30	$18,666,326	295,400	+172.0%	Put	Sole	2020-11-16
2020-09-30	$19,866,936	314,400	+283.4%	Call	Sole	2020-11-16
2020-06-30	$6,309,080	82,000	+69.4%	Call	Sole	2020-08-14
2020-06-30	$8,355,684	108,600	+362.1%	Put	Sole	2020-08-14
2020-03-31	$1,756,860	23,500	—	Put	Sole	2020-05-15
2020-03-31	$2,674,389	35,773	—	Shares	Sole	2020-05-15
2020-03-31	$3,618,384	48,400	—	Call	Sole	2020-05-15
No filing history on record for this holder in this stock.